Metrasens greatly values its intellectual property rights and will continue to take all necessary legal and commercial steps to protect its proprietary technology and patents
MALVERN, England (PRWEB) August 13, 2019
Metrasens, a global leader of MRI Safety solutions for healthcare facilities, announces that on 5th August 2019 it filed a new patent infringement case with Shanghai Intellectual Property Court against Nanjing Cloud Magnet Electronic Technology Limited.
Metrasens is a leading provider of advanced magnetic detection technologies. Founded in the UK, Metrasens has become a global industry leader in the provision of patient safety solutions to MRI facilities. Its Ferroguard® products have built a reputation as trustworthy ferromagnetic detection systems (FMDS) and are in use in 36 countries.
Metrasens has previously commenced action in China, in Nanjing Intermediate People's Court, against Nanjing Cloud Magnet Electronic Technology Limited 南京云磁电子科技有限公司 (“Cloud Magnet”) and its affiliate Nanjing Haole Technology Co., Ltd 南京浩乐科技有限公司 (“NH”) for infringement of Metrasens’ granted patents, and copyright materials.
The patent infringement case alleges Cloud Magnet has continued to actively and publicly promote its products which we believe infringe Metrasens’ patents granted in China, including in particular, the promotion and offer to sell these products at an exhibition in Shanghai. Consequently, Metrasens has filed a new patent infringement case with the Shanghai Intellectual Property Court on 5 August 2019 (Case Re: (2019) Hu 73 ZhiMin Chu No. 599). We trust Shanghai Intellectual Property Court, as one of the specialized intellectual property courts in China, will render a decision according to the laws. In order to avoid parallel trials, we are going to combine the infringement asserted at the Nanjing into the case to be tried by the specialist Shanghai Intellectual Property Court and withdraw the patent infringement case with the Nanjing Court.
Metrasens greatly values the relationships that it has developed with the Chinese radiology community through its adoption of Ferroguard MRI safety systems over the past six years. Similarly, it greatly respects the development within China of new technologies to advance the goal of making MRI facilities as safe as possible for all patients and staff. However, Metrasens values its intellectual property rights and will continue to take all necessary legal and commercial steps to protect its proprietary technology and patents.
Metrasens is the world’s leading provider of advanced magnetic detection technologies. Our innovative products are designed to address deficiencies in conventional screening methods, to make us all safer and more secure. Our mission is to take great science from the laboratory and use it to create revolutionary, award-winning products which meet the real needs of our customers. Metrasens’ core technologies have an extremely wide range of potential applications. Innovation is at the core of everything we do – from research and development, through to customer service and training.
Metrasens has grown rapidly to become a dynamic international business, and the acknowledged leader in our chosen markets. Our Technology Centre and manufacturing facility are located in the UK, and we have established a global network of distributors. Our developments continue to enable new customers, working in increasingly complex environments, to achieve higher levels of safety and security.